An official website of the United States government
Home
Name
Axitinib
Alternate Names
AG 013736
AG-013736
AG013736
Inlyta
Abbreviations
None
Category
Chemotherapy
Subcategory
Tyrosine kinase inhibitor
NSC Number
None
Primary Site
Colorectal
kidney
melanoma
pancreas
thyroid
Histology
None
Remarks
January 27, 2012: FDA approved Inlyta (axitinib) to treat patients with advanced kidney cancer (renal cell carcinoma) who have not responded to otherr drugs for this type of cancer.
Orphan drug for pancreas, thyroid
Orphan drug for pancreas, thyroid
Coding
This drug should be coded
